FDA Inspection 574282 — Medtronic Neuromodulation

Medtronic Neuromodulation — FEI 2182207

The FDA completed an inspection of Medtronic Neuromodulation on Mar 24, 2009 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 24, 2009
Fiscal Year
2009
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Minneapolis, MN (United States)